PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival

Kambiz Rahbar(University Hospital Münster), Martin Boegemann(University Hospital Münster), Anna Yordanova(University Hospital Bonn), Maria Eveslage(University Hospital Münster), Michael Schäfers(University Hospital Münster), Markus Essler(University Hospital Bonn), Hojat Ahmadzadehfar(University Hospital Bonn)
European Journal of Nuclear Medicine and Molecular Imaging
October 12, 2017
Cited by 160

Abstract


Related Papers

No related papers found

Powered by citation graph analysis